About Joost Bakker

This author has not yet written his bio.
Meanwhile let's just say that we are proud Joost Bakker contributed with 50 entries.

Entries by Joost Bakker

Scientific Review Endorses ISA Pharmaceuticals’ Strategy to Overcome Immune Evasion in Cancer Immunotherapy

ISA Pharmaceuticals Appoints Gerben Moolhuizen as Chief Business Development Officer

ISA Pharmaceuticals’ ISA101 Studied in Phase II Combination Trial with Checkpoint Inhibitor Nivolumab

Towards a Best Practice Approach in Cancer Immunotherapy: Cancer Vaccines Gain Momentum

ISA Pharmaceuticals Further Strengthens IP Position on Lead Compound ISA101

New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP® Immunotherapeutics

ISA Pharmaceuticals Granted European Patent for the Intradermal Administration of ISA101

ISA Pharmaceuticals signs R&D agreement with Shin Nippon Biomedical Laboratories

ISA Pharmaceuticals announces start of first Phase I/II clinical trial of its SLP®-AMPLIVANT® conjugates

Publication in Nature Supports ISA Pharmaceuticals´ Synthetic Long Peptide Immunotherapeutic Approach to Treat Cancer